| Trial registration number
|
NCT04959786 |
Full text link
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04959786
|
First author
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Hatem elalfy, MD
|
Contact
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
ELALFY2004@MANS.EDU.EG
|
Registration date
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
2021-07-13
|
Recruitment status
Last imported at : July 6, 2023, midnight
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- aged ≥18 years
- laboratory-confirmed sars-cov- 2 infection
- hospitalized patients
- need reservoir mask for oxygen support
- need hfnc for oxygen support
|
Exclusion criteria
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
- mechanical ventilations for oxygen support
- inability to take oral medications
- pregnancy or breastfeeding
|
Number of arms
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Mansoura University
|
Inclusion age min
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
100
|
primary outcome
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
In-hospital and 28-day mortality;Stabilization of oxygen
|
Notes
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
Phase 2/Phase 3
|
Arms
Last imported at : July 14, 2021, 6 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 2302, "treatment_name": "Ivermectin+nitazoxanide+ribavirin+zinc", "treatment_type": "Antiparasitics+antivirals+vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|